Technical Analysis for ZLAB - Zai Lab Limited

Grade Last Price % Change Price Change
grade A 29.11 -2.74% -0.82
ZLAB closed down 2.74 percent on Friday, March 22, 2019, on 37 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical ZLAB trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 Bollinger Band Squeeze Range Contraction -2.74%
Mar 21 Upper Bollinger Band Walk Strength -2.74%
Mar 21 Overbought Stochastic Strength -2.74%
Mar 20 Bollinger Band Squeeze Range Contraction -3.10%
Mar 20 Upper Bollinger Band Walk Strength -3.10%
Mar 20 Multiple of Ten Bullish Other -3.10%
Mar 20 BB Squeeze + Upper Band Touch Range Contraction -3.10%

Older signals for ZLAB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zai Lab Ltd, incorporated on March 28, 2017, is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.
Biopharmaceutical Pharmaceutical Industry Natural Sciences Medication
Is ZLAB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.86
52 Week Low 14.29
Average Volume 177,530
200-Day Moving Average 22.4345
50-Day Moving Average 27.8792
20-Day Moving Average 28.8895
10-Day Moving Average 29.092
Average True Range 1.276
ADX 21.9
+DI 22.1575
-DI 17.1305
Chandelier Exit (Long, 3 ATRs ) 27.152
Chandelier Exit (Short, 3 ATRs ) 29.838
Upper Bollinger Band 30.3233
Lower Bollinger Band 27.4557
Percent B (%b) 0.58
BandWidth 9.926098
MACD Line 0.5275
MACD Signal Line 0.4995
MACD Histogram 0.028
Fundamentals Value
Market Cap 1.43 Billion
Num Shares 49.1 Million
EPS -4.94
Price-to-Earnings (P/E) Ratio -5.89
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.35
Resistance 3 (R3) 30.45 30.14 30.14
Resistance 2 (R2) 30.14 29.83 30.09 30.07
Resistance 1 (R1) 29.63 29.63 29.47 29.52 30.01
Pivot Point 29.31 29.31 29.24 29.26 29.31
Support 1 (S1) 28.80 29.00 28.64 28.70 28.21
Support 2 (S2) 28.49 28.80 28.44 28.15
Support 3 (S3) 27.97 28.49 28.08
Support 4 (S4) 27.87